$MACK Merrimack Pharmaceuticals’ (MACK) “Market Perform” Rating Reaffirmed at Cowen and Company MACK Merrimack Pharmaceuticals currently has a consensus rating of Hold and a consensus target price of $8.27. https://sportsperspectives.com/2017/05/22/merrimack-pharmaceuticals-mack-market-perform-rating-reaffirmed-at-cowen-and-company.html http://stockcharts.com/c-sc/sc?s=mack&p=D&b=5&g=0&i=p24597972749&r=1363673449596%5B/img%5D%5B/img%5D Go $MACK